Comparativa de certolizumab pegol con agentes anticytokine otros para el tratamiento de la artritis reumatoide: un meta-análisis bayesiano múltiples tratamientos

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2012
Cargando información sobre las referencias

CRD SUMMARY:

This review reported that certolizumab pegol was at least as efficacious as pre-existing antirheumatic anti-cytokine biotherapies for the treatment of rheumatoid arthritis. Review data appeared to support the authors' conclusions, but the risk of missing data and the clinical differences between the included studies suggest that the findings may not be reliable.
Epistemonikos ID: 59d0b7fdfa3b85ed153afa4a0994de0ff97a0855
First added on: Jun 06, 2012